Chemotherapy-related cognitive dysfunction: Current animal studies and future directions

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 453-459

  Seigers, R ^a   Schagen, S B ^a   Van Tellingen, O ^a   Dietrich, J ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Animal; Chemotherapy; Cognition; Cytostatic; Impairment; Review

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; FLUOXETINE; IFOSFAMIDE; MELATONIN; METHOTREXATE; PACLITAXEL; SOMATOMEDIN C; TEMOZOLOMIDE; THIOTEPA; TRANSCRIPTION FACTOR; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; APOPTOSIS; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; COGNITIVE DEFECT; EXPERIMENTAL ANIMAL; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; EVIDENCE-BASED MEDICINE; FORECASTING; HUMANS; NEOPLASMS;

EID: 84897098517     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9250-3     Document Type: Review

References (82)

1. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7, 192-201.
2. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
3. Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440.
4. Akiba, T., Okeda, R., & Tajima, T. (1996). Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathologica, 92, 8-13.
5. Aluise, C. D., Miriyala, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T. J., et al. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-alpha release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology and Medicine, 50, 1630-1638.
6. Bhatia, A. L., Manda, K., Patni, S., & Sharma, A. L. (2006). Prophylactic action of linseed (Linum usitatissimum) oil against cyclophosphamide-induced oxidative stress inmouse brain. Journal of Medicinal Food, 9, 261-264.
7. Briones, T. L., & Woods, J. (2011). Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neuroscience, 12, 124.
8. Cata, J. P., Weng, H. R., & Dougherty, P. M. (2008). The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Research, 1229, 100-110.
9. Christie, L. A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012). Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clinical Cancer Research, 18, 1954-1965.
10. Das, S., & Basu, A. (2008). Inflammation: a new candidate in modulating adult neurogenesis. Journal of Neuroscience Research, 86, 1199-1208.
11. de Vos, F. Y., Willemse, P. H., De Vries, E. G., & Gietema, J. A. (2004). Endothelial cell effects of cytotoxics: balance between desired and unwanted effects. Cancer Treatment Reviews, 30, 495-513.
12. Dietrich, J., Han, R., Yang, Y., Mayer-Proschel, M., & Noble, M. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biological, 5, 22.
13. Dietrich, J., Monje, M., Wefel, J., & Meyers, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist, 13, 1285-1295.
14. Eijkenboom, M., & Van Der Staay, F. J. (1999). Spatial learning deficits in rats after injection of vincristine into the dorsal hippocampus. Neuroscience, 91, 1299-1313.
15. Ekdahl, C. T., Claasen, J. H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003). Inflammation is detrimental for neurogenesis in adult brain. Proceedings of the National Academy of Sciences of the United States of America, 100, 13632-13637.
16. ElBeltagy, M., Mustafa, S., Umka, J., Lyons, L., Salman, A., Chur-yoe, G. T., et al. (2010). Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behavioural Brain Research, 208, 112-117.
17. ElBeltagy, M., Mustafa, S., Umka, J., Lyons, L., Salman, A., Dormon, K., et al. (2012). The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus. Brain Research Bulletin, 88, 514-518.
18. Gandal, M. J., Ehrlichman, R. S., Rudnick, N. D., & Siegel, S. J. (2008). A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience, 157, 95-104.
19. Gietema, J. A., Meinardi, M. T., Messerschmidt, J., Gelevert, T., Alt, F., Uges, D. R., et al. (2000). Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer. Lancet, 355, 1075-1076.
20. Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Proschel, M., & Noble, M. (2008). Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. Journal of Biological, 7, 12.
21. Hanisch, U. K., & Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience, 10, 1387-1394.
22. Helal, G. K., Aleisa, A. M., Helal, O. K., Al Rejaie, S. S., Al Yahya, A. A., AlMajed, A. A., et al. (2009). Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats. Oxidative Medicine and Cellular Longevity, 2, 26-35.
23. Hyrien, O., Dietrich, J., & Noble, M. (2010). Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors. Cancer Research, 70, 10051-10059.
24. Janelsins, M. C., Roscoe, J. A., Berg, M. J., Thompson, B. D., Gallagher, M. J., Morrow, G. R., et al. (2010). IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Investigation, 28, 544-553.
25. Joshi, G., Sultana, R., Tangpong, J., Cole, M. P., St Clair, D. K., Vore, M., et al. (2005). Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radical Research, 39, 1147-1154.
26. Joshi, G., Hardas, S., Sultana, R., St Clair, D. K., Vore, M., & Butterfield, D. A. (2007). Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain. Journal of Neuroscience Research, 85, 497-503.
27. Joshi, G., Aluise, C. D., Cole, M. P., Sultana, R., Pierce, W.M., Vore, M., et al. (2010). Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stressmediated chemobrain. Neuroscience, 166, 796-807.
28. Kaya, E., Keskin, L., Aydogdu, I., Kuku, I., Bayraktar, N., &Erkut, M. A. (2005). Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma. Journal of International Medical Research, 33, 687-692.
29. Kennedy, D. D., Ladas, E. J., Rheingold, S. R., Blumberg, J., & Kelly, K. M. (2005). Antioxidant status decreases in children with acute lymphoblastic leukemia during the first sixmonths of chemotherapy treatment. Pediatric Blood & Cancer, 44, 378-385.
30. Konat, G. W., Kraszpulski, M., James, I., Zhang, H. T., & Abraham, J. (2008). Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metabolic Brain Disease, 23, 325-333.
31. Koppelmans, V., Breteler, M.M., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30, 1080-1086.
32. Koros, C., & Kitraki, E. (2009). Neurofilament isoform alterations in the rat cerebellum following cytosine arabinoside administration. Toxicology Letters, 189, 215-218.
33. Koros, C., Papalexi, E., Anastasopoulos, D., Kittas, C., & Kitraki, E. (2007). Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat. A possible protective role of NAC. Neurotoxicology, 28, 83-92.
34. Lau, B. W., Yau, S. Y., Lee, T. M., Ching, Y. P., Tang, S. W., & So, K. F. (2009). Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption. Neuroreport, 20, 371-377.
35. Li, C. Q., Liu, D., Huang, L., Wang, H., Zhang, J. Y., & Luo, X. G. (2008). Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats. Brain Research Bulletin, 77, 237-240.
36. Li, Y., Vijayanathan, V., Gulinello, M., & Cole, P. D. (2010a). Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine. Pharmacology Biochemistry and Behavior, 95, 428-433.
37. Li, Y., Vijayanathan, V., Gulinello, M. E., & Cole, P. D. (2010b). Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats. Pharmacology Biochemistry and Behavior, 94, 454-463.
38. Licht, T., Goshen, I., Avital, A., Kreisel, T., Zubedat, S., Eavri, R., et al. (2011). Reversible modulations of neuronal plasticity by VEGF. Proceedings of the National Academy of Sciences of the United States of America, 108, 5081-5086.
39. Liedke, P. E., Reolon, G. K., Kilpp, B., Brunetto, A. L., Roesler, R., & Schwartsmann, G. (2009). Systemic administration of doxorubicin impairs aversively motivated memory in rats. Pharmacology Biochemistry and Behavior, 94, 239-243.
40. Long, J. M., Lee, G. D., Kelley-Bell, B., Spangler, E. L., Perez, E. J., Longo, D. L., et al. (2011). Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats. Pharmacology Biochemistry and Behavior, 100, 205-211.
41. Lyons, L., ElBeltagy, M., Bennett, G., & Wigmore, P. (2011a). The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat. PLoS One, 6, e21445.
42. Lyons, L., ElBeltagy, M., Umka, J., Markwick, R., Startin, C., Bennett, G., et al. (2011b). Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. Psychopharmacology (Berl), 215, 105-115.
43. Lyons, L., ElBeltagy, M., Bennett, G., &Wigmore, P. (2012). Fluoxetine counteracts the cognitive and cellular effects of 5-Fluorouracil in the rat hippocampus by amechanism of prevention rather than recovery. PLoS One, 7, e30010.
44. Madhyastha, S., Somayaji, S. N., Rao, M. S., Nalini, K., & Bairy, K. L. (2002). Hippocampal brain amines in methotrexate-induced learning and memory deficit. Canadian Journal of Physiology and Pharmacology, 80, 1076-1084.
45. Manda, K., & Bhatia, A. L. (2003). Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biology and Toxicology, 19, 367-372.
46. Mignone, R. G., & Weber, E. T. (2006). Potent inhibition of cell proliferation in the hippocampal dentate gyrus of mice by the chemotherapeutic drug thioTEPA. Brain Research, 1111, 26-29.
47. Mondie, C. M., Vandergrift, K. A., Wilson, C. L., Gulinello, M. E., & Weber, E. T. (2010). The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors inmice. Behavioural Brain Research, 209, 66-72.
48. Monje, M., & Dietrich, J. (2012). Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behavioural Brain Research, 227, 376-379.
49. Mustafa, S., Walker, A., Bennett, G., & Wigmore, P. M. (2008). 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. European Journal of Neuroscience, 28, 323-330.
50. Nokia, M. S., Sisti, H.M., Choksi, M. R., & Shors, T. J. (2012). Learning to learn: theta oscillations predict new learning, which enhances related learning and neurogenesis. PLoS One, 7, e31375.
51. Oboh, G., & Ogunruku, O. O. (2010). Cyclophosphamide-induced oxidative stress in brain: protective effect of hot short pepper (Capsicum frutescens L. var. abbreviatum). Experimental and Toxicologic Pathology, 62, 227-233.
52. Oboh, G., Akomolafe, T. L., Adefegha, S. A., & Adetuyi, A. O. (2011). Inhibition of cyclophosphamide-induced oxidative stress in rat brain by polar and non-polar extracts of Annatto (Bixa orellana) seeds. Experimental and Toxicologic Pathology, 63, 257-262.
53. Öz, E., & Ilhan, M. N. (2006). Effects of melatonin in reducing the toxic effects of doxorubicin. Molecular and Cellular Biochemistry, 286, 11-15.
54. Palmer, T. D., Willhoite, A. R., & Gage, F. H. (2000). Vascular niche for adult hippocampal neurogenesis. Journal of Comparative Neurology, 425, 479-494.
55. Papageorgiou, M., Stiakaki, E., Dimitriou, H., Malliaraki, N., Notas, G., Castanas, E., et al. (2005). Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignancies. Leukemia Research, 29, 11-16.
56. Rajamani, R., Muthuvel, A., Senthilvelan, M., & Sheeladevi, R. (2006). Oxidative stress induced by methotrexate alone and in the presence of methanol in discrete regions of the rodent brain, retina and optic nerve. Toxicology Letters, 165, 265-273.
57. Ransohoff, R. M., & Perry, V. H. (2009). Microglial physiology: unique stimuli, specialized responses. Annual Review of Immunology, 27, 119-145.
58. Rzeski, W., Pruskil, S., Macke, A., Felderhoff-Mueser, U., Reiher, A. K., Hoerster, F., et al. (2004). Anticancer agents are potent neurotoxins in vitro and in vivo. Annals of Neurology, 56, 351-360.
59. Sebolt-Leopold, J. S., & English, J. M. (2006). Mechanisms of drug inhibition of signalling molecules. Nature, 441, 457-462.
60. Seigers, R., & Fardell, J. E. (2011). Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neuroscience & Biobehavioral Reviews, 35, 729-741.
61. Seigers, R., Schagen, S. B., Beerling, W., Boogerd, W., van Tellingen, O., van Dam, F. S., et al. (2008). Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behavioural Brain Research, 186, 168-175.
62. Seigers, R., Schagen, S. B., Coppens, C. M., van derMost, P. J., van Dam, F. S., Koolhaas, J. M., et al. (2009). Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behavioural Brain Research, 2, 279-284.
63. Seigers, R., Pourtau, L., Schagen, S. B., van Dam, F. S., Koolhaas, J.M., Konsman, J. P., et al. (2010a). Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Research Bulletin, 81, 472-476.
64. Seigers, R., Timmermans, J., van der Horn, H. J., de Vries, E. F., Dierckx, R. A., Visser, L., et al. (2010b). Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behavioural Brain Research, 207, 265-272.
65. Silverman, D.H., Dy, C. J., Castellon, S.A., Lai, J., Pio, B.S., Abraham, L., et al. (2006). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103, 303-311.
66. Silverstein, F. S., & Johnston, M. V. (1986). A model of methotrexate encephalopathy: neurotransmitter and pathologic abnormalities. Journal of Child Neurology, 1, 351-357.
67. Smith, J., Ladi, E., Mayer-Proschel, M., & Noble, M. (2000). Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proceedings of the National Academy of Sciences of the United States of America, 97, 10032-10037.
68. Tangpong, J., Cole, M. P., Sultana, R., Joshi, G., Estus, S., Vore, M., et al. (2006). Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiology of Disease, 23, 127-139.
69. Tangpong, J., Cole, M. P., Sultana, R., Estus, S., Vore, M., St, C.W., et al. (2007). Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. Journal of Neurochemistry, 100, 191-201.
70. Tangpong, J., Miriyala, S., Noel, T., Sinthupibulyakit, C., Jungsuwadee, P., & St Clair, D. K. (2011). Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuroscience, 175, 292-299.
71. Vijayanathan, V., Gulinello, M., Ali, N., & Cole, P. D. (2011). Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist. Behavioural Brain Research, 225, 491-497.
72. Wang, J., Ren, K., Perez, J., Silva, A. J., & de Pena, O. S. (2003). The antimetabolite ara-CTP blocks long-term memory of conditioned taste aversion. Learning & Memory, 10, 503-509.
73. Wefel, J. S., & Schagen, S. B. (2012). Chemotherapy-related cognitive dysfunction. Current Neurology and Neuroscience Reports, 12, 267-275.
74. Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004). Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. British Journal of Cancer, 90, 1691-1696.
75. Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116, 3348-3356.
76. Weijl, N. I., Hopman, G. D., Wipkink-Bakker, A., Lentjes, E. G., Berger, H. M., Cleton, F. J., et al. (1998). Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Annals of Oncology, 9, 1331-1337.
77. Wilson, C. L., & Weber, E. T. (2013). Chemotherapy drug thioTEPA exacerbates stress-induced anhedonia and corticosteroid responses but not impairment of hippocampal cell proliferation in adult mice. Behavioural Brain Research, 236, 180-185.
78. Winocur, G., Binns, M. A., & Tannock, I. (2011). Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology, 61, 1222-1228.
79. Winocur, G., Henkelman, M., Wojtowicz, J.M., Zhang, H., Binns, M. A., & Tannock, I. F. (2012). The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clinical Cancer Research, 18, 3112-3121.
80. Yang, M., Kim, J. S., Song, M. S., Kim, S. H., Kang, S. S., Bae, C. S., et al. (2010). Cyclophosphamide impairs hippocampusdependent learning and memory in adult mice: Possible involvement of hippocampal neurogenesis in chemotherapyinduced memory deficits. Neurobiology of Learning and Memory, 93, 487-494.
81. Yang, M., Kim, J. S., Kim, J., Kim, S. H., Kim, J. C., Kim, J., et al. (2011). Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro. Biochemical Pharmacology, 82, 72-80.
82. Yang, M., Kim, J. S., Kim, J., Jang, S., Kim, S. H., Kim, J. C., et al. (2012). Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer. Brain Research Bulletin, 89, 50-56.